Generated by Llama 3.3-70Binfluenza viruses are a significant cause of morbidity and mortality worldwide, affecting millions of people every year, particularly during the flu season, as reported by the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC). The impact of influenza viruses is evident in the Spanish flu pandemic of 1918, which was one of the deadliest natural disasters in human history, and more recently, the 2009 flu pandemic, which was caused by the H1N1 virus. Influenza viruses have also been the subject of extensive research by scientists such as Robert Webster, Jeffrey Taubenberger, and Peter Palese, who have made significant contributions to our understanding of these viruses. The study of influenza viruses is a collaborative effort involving organizations such as the National Institutes of Health (NIH), the European Centre for Disease Prevention and Control (ECDC), and the Food and Agriculture Organization (FAO) of the United Nations.
Influenza viruses are a type of RNA virus that belongs to the family Orthomyxoviridae, which also includes the Thogotovirus and Isavirus. These viruses are known to infect a wide range of hosts, including humans, birds, pigs, and horses, as well as other mammals and birds, and have been studied by researchers at institutions such as the University of Oxford, the University of Cambridge, and the Harvard School of Public Health. The WHO and the CDC work together to monitor and track the spread of influenza viruses, including the H5N1 virus and the H7N9 virus, which have been associated with outbreaks in Asia and Europe. The US Department of Health and Human Services and the European Commission have also developed strategies to combat the spread of influenza viruses, including the development of vaccines and antiviral medications.
Influenza viruses are classified into four main types: Influenza A virus, Influenza B virus, Influenza C virus, and Influenza D virus. The Influenza A virus is further divided into subtypes based on the hemagglutinin (H) and neuraminidase (N) proteins on its surface, such as H1N1 and H3N2, which have been studied by researchers at the University of California, Los Angeles (UCLA) and the University of Wisconsin–Madison. The Influenza B virus is also divided into subtypes, including B/Yamagata and B/Victoria, which have been identified by scientists at the National Institute of Allergy and Infectious Diseases (NIAID) and the European Molecular Biology Laboratory (EMBL). The Influenza C virus and Influenza D virus are less common and typically cause mild infections, as reported by the CDC and the WHO.
Influenza viruses have a complex structure, consisting of a lipid bilayer envelope and a helical nucleocapsid core, which has been studied by researchers using electron microscopy and X-ray crystallography at institutions such as the University of California, San Francisco (UCSF) and the Massachusetts Institute of Technology (MIT). The viral genome consists of eight single-stranded RNA segments, which encode for 10-12 proteins, including the hemagglutinin and neuraminidase proteins, as well as the nucleoprotein and matrix protein, which have been characterized by scientists at the National Institute of General Medical Sciences (NIGMS) and the European Research Council (ERC). The genetic variation of influenza viruses is high, which allows them to rapidly evolve and adapt to new hosts and environments, as reported by the WHO and the CDC.
Influenza viruses are primarily transmitted through the airborne route, where infected individuals release viral particles into the air through coughing and sneezing, which can be studied using computational models developed by researchers at the University of Michigan and the University of California, Berkeley. The viruses can also be transmitted through contact transmission, where infected individuals come into contact with contaminated surfaces or objects, as reported by the CDC and the WHO. Once inside the host cell, the virus undergoes replication, where it produces new viral particles using the host cell's machinery, as studied by researchers at the University of Geneva and the University of Tokyo.
The symptoms of influenza virus infection can range from mild to severe and include fever, cough, sore throat, and fatigue, as reported by the CDC and the WHO. In severe cases, influenza virus infection can lead to pneumonia, acute respiratory distress syndrome (ARDS), and even death, as studied by researchers at the University of Washington and the University of Chicago. Diagnosis of influenza virus infection is typically made using rapid diagnostic tests (RDTs), such as PCR and ELISA, which can detect the presence of viral antigens or nucleic acids in respiratory samples, as developed by scientists at the University of California, Los Angeles (UCLA) and the University of Oxford.
Treatment of influenza virus infection typically involves the use of antiviral medications, such as oseltamivir and zanamivir, which can help reduce the severity and duration of symptoms, as reported by the CDC and the WHO. Vaccination is also an effective way to prevent influenza virus infection, with vaccines available for seasonal influenza and pandemic influenza, as developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID) and the University of California, San Francisco (UCSF). Other preventive measures include hand hygiene, respiratory etiquette, and social distancing, which can help reduce the transmission of influenza viruses, as recommended by the WHO and the CDC. Category:Virology